Velocity Clinical buys 2 clinical trial networks
Velocity Clinical Research has acquired two companies that operate research trial networks: VitaLink Research and the National Research Institute. Velocity Clinical did not disclose the amount it paid for the firms. Read More
Pfizer-BioNTech COVID-19 vaccine safe for kids ages 5-11
Pfizer and BioNTech's COVID-19 vaccine is safe and well tolerated and showed robust neutralizing antibody responses in children between the ages of 5 and 11, according to clinical trial results. Read More
AI model predicts oxygen needs of COVID-19 patients
Researchers have trained an artificial intelligence (AI) model to predict the future oxygen needs of symptomatic patients with COVID-19, according to a study published in Nature Medicine on September 15. Read More
Thermo Fisher awarded $193M for pipette tip production
Thermo Fisher Scientific will receive $193 million in a contract award from the U.S. Department of Defense to help establish U.S. production of pipette tips. Read More
Meeting on the Mesa ramps up rules on COVID-19 vaccination, testing
The Alliance for Regenerative Medicine has implemented new rules for its Cell & Gene Meeting on the Mesa, which is scheduled for October 12-14, 2021, that require attendees to either provide proof of vaccination from COVID-19 or a negative COVID test. Read More
COVID multiomics dataset, portal go online for public use
A new multidimensional dataset for COVID-19 multiomics research has been released to the public, along with a free online research portal for analyzing the data. The COVIDome Explorer and dataset, described recently in Cell Reports, give researchers a way to share data and collaborate in real-time for the clinical management of COVID-19. Read More
McMaster, Sartorius partner on improving biomanufacturing
Sartorius Stedim Biotech and McMaster University, which is located in Hamilton, Ontario, Canada, plan to collaborate on an effort to improve advanced manufacturing processes for antibody and virus-based treatments for diseases like COVID-19 and cancer. Read More
Valneva begins U.K. approval process for COVID-19 vaccine
French firm Valneva has begun the regulatory submission process to the U.K.'s Medicines and Healthcare products Regulatory Agency for its COVID-19 vaccine candidate, VLA2001. Read More
FDA authorizes 3rd COVID vaccine dose for immunocompromised individuals
The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations for both the Pfizer-BioNTech and Moderna COVID-19 vaccines. Read More
Novavax COVID-19 vaccine booster appears effective after primary vaccination
Novavax announced preliminary data indicating that a single booster dose of the company's recombinant nanoparticle protein-based COVID-19 vaccine drew a 4.6-fold increase in functional antibody titers. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter